Effects of tobacco smoke condensate on estrogen receptor-α gene expression and activity

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4676-4686

  Martin, Mary Beth ^a   Reiter, Ronald ^a   Johnson, Michael ^a   Shah, Mansi S ^c   Iann, Mary C ^c   Singh, Baljit ^a   Richards, Julie Kate ^c   Wang, Antai ^b   Stoica, Adriana ^a,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; LUCIFERASE; PROGESTERONE RECEPTOR; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL GROWTH; CELL STRAIN COS1; CELL STRAIN MCF 7; CHO CELL; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REPORTER GENE; SPRAGUE DAWLEY RAT; STATISTICAL ANALYSIS; TOBACCO; UTERUS WEIGHT; WILD TYPE;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMANS; MUTATION; OSMOLAR CONCENTRATION; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SMOKE; TOBACCO; TRANSFECTION;

EID: 34748849182     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0208     Document Type: Article

References (75)

1. American Cancer Society 2004 Cancer facts and figures 2004. Atlanta: American Cancer Society
2. Richie RC, Swanson JO 2003 Breast cancer: a review of the literature. J Insur Med 35:85-101
3. Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE 2004 Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 13:220-224
4. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T 1993 The lifetime risk of developing breast cancer. J Natl Cancer Inst 85:892-897
5. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA 2005 Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34:405-412
6. Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC, Martin MB 1994 Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 269:16896-16901
7. Stoica A, Katzenellenbogen BS, Martin MB 2000 Activation of estrogen receptor-α by the heavy metal cadmium. Mol Endocrinol 14:545-553
8. Stoica A, Pentecost E, Martin MB 2000 Effects of arsenite on estrogen receptor-α expression and activity in MCF-7 breast cancer cells. Endocrinology 141:3595-3602
9. Stoica A, Pentecost E, Martin MB 2000 Effects of selenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells. J Cell Biochem 79:282-292
10. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Palk S, Martin MB 2003 Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9:1081-1084
11. Martin MB, Reiter R, Pham T, Avellanet YR, Camara J, Lahm M, Pentecost E, Pratap K, Gilmore B, Divekar S, Dagata RS, Bull J, Stoica A 2003 Estrogen like activity of metals in MCF-7 breast cancer cells. Endocrinology 144:2425-2436
12. Safe S 2003 Cadmium's disguise dupes the estrogen receptor. Nat Med 9:1000-1001
13. Bernhard D, Rossmann A, Wick G 2005 Metals in cigarette smoke. IUBMB Life 57:805-809
14. Phillips DH 1996 DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. Environ Health Perspect 104(Suppl 3):453-458
15. Smith CJ, Livingston SD, Doolittle DJ 1997 An international literature survey of "IARC Group I carcinogens" reported in mainstream cigarette smoke. Food Chem Toxicol 35:1107-1130
16. Gammon MD, Wolff MS, Neugut AI, Eng SM, Teitelbaum SL, Britton JA, Terry MB, Levin B, Stellman SD, Kabat GC, Hatch M, Senie R, Berkowitz G, Bradlow HL, Garbowski G, Maffeo C, Montalvan P, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S, Vinceguerra V, Niguidula N, Ireland K, Santella RM 2002 Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 11:686-697
17. Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, Levin B, Terry MB, Young TL, Wang LW, Wang Q, Britton JA, Wolff MS, Stellman SD, Hatch M, Kabat GC, Senie R, Garbowski G, Maffeo C, Montalvan P, Berkowitz G, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S, Vinceguerra V 2002 Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 11:677-685
18. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M 2006 Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40
19. Hoffmann D, Djordjevic MV, Hoffmann I 1997 The changing cigarette. Prev Med 26:427-434
20. Nanni EJ, Lovette ME, Hicks RD, Fowler KW, Borgerding MF 1990 Separation and quantitation of monovalent anionic and cationic species in mainstream cigarette smoke aerosols by high-performance ion chromatography. J Chromatogr Sci 28:432-436
21. Saceda M, Lippman ME, Chambon P, Lindsey RK, Pongliktmongkol M, Puente M, Martin MB 1988 Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2:1157-1162
22. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P 1982 Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line. Nucleic Acids Res 10:7895-7903
23. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG 1993 Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res 53:2168-2177
24. Martin MB, Voeller HJ, Gelmann EP, Lu J, Stoica EG, Hebert EJ, Reter R, Singh B, Danielsen M, Pentecost E, Stocia A 2002 Role of cadmium in the regulation of AR gene expression and activity. Endocrinology 143:263-275
25. Reese JC, Katzenellenbogen BS 1991 Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. J Biol Chem 266:10880-10887
26. Wrenn CK, Katzenellenbogen BS 1993 Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J Biol Chem 268:24089-24098
27. Pakdel F, Katzenellenbogen BS 1992 Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination. J Biol Chem 267:3429-3437
28. Pakdel F, Reese JC, Katzenellenbogen BS 1993 Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor. Mol Endocrinol 7:1408-1417
29. El-Ashry D, Chrysogelos SA, Lippman ME, Kern FG 1996 Estrogen induction of TGF-alpha is mediated by an estrogen response element composed of two imperfect palindromes. J Steroid Biochem Mol Biol 59:261-269
30. Webster NJ, Green S, Jin JR, Chambon P 1988 The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcriptional activation function. Cell 54:199-207
31. Reiter R, Wellstein A, Riegel AT 2001 An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer. J Biol Chem 276:39736-39741
32. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD, Martin MB 1997 The role of transforming growth factor-β in the regulation of estrogen receptor expression in the MCF-7 breast cancer cell line. Endocrinology 138:1498-1505
33. Scatchard G 1949 The attractions of protein for small molecules and ions. Ann NY Acad Sci 51:660-672
34. Meek MD, Finch GL 1999 Diluted mainstream cigarette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription. Environ Res 80:9-17
35. Smith CL 1998 Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 58:627-632
36. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H 1996 A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3:87-94
37. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1996 Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689
38. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375:377-382
39. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J, Carlquist M 1997 Molecular basis of agonism and antagonism in the estrogen receptor. Nature 389:753-758
40. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
41. Tanenbaum DM, Wang Y, Williams SP, Sigler PB 1998 Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domain. Proc Natl Acad Sci USA 95:5998-6003
42. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
43. Ramamoorthy K, Wang F, Chen IC, Safe S, Norris JD, McDonnell DP, Gaido KW, Bocchinfuso WP, Korach KS 1997 Potency of combined estrogenic pesticides. Science 275:405-406
44. Anstead GM, Kym PR 1995 Benzanthracene diols: predicted carcinogenicity and structure-estrogen receptor binding affinity relationships. Steroids 60:383-394
45. Dickerson R, Keller LH, Safe S 1995 Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies. Toxicol Appl Pharmacol 135:287-298
46. Wormke M, Stoner M, Saville B, Walker K, Abdelrahim M, Burghardt R, Safe S 2003 The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Mol Cell Biol 23:1843-1855
47. Khan S, Barhoumi R, Burghardt R, Liu S, Kim K, Safe S 2006 Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells. Mol Endocrinol 20:2199-2214
48. Antila E, Mussalo-Rauhamaa H, Kantola M, Atroshi F, Westermarck T 1996 Association of cadmium with human breast cancer. Sci Total Environ 186:251-256
49. Ionescu JG, Novotny J, Stejskal VD, Latsch A, Blaurock-Busch E, Eisenmann-Klein M 2006 Increased levels of transition metals in breast cancer tissue. Neuro Endocrinol Lett 27:1-3
50. Koksoy C, Kavas GO, Akcil E, Kocaturk PA, Kara S, Ozarslan C 1997 Trace elements and superoxide dismutase in benign and malignant breast diseases. Breast Cancer Res Treat 45:1-6
51. Capel ID, Pinnock MH, Williams DC, Hanham IW 1982 The serum levels of some trace and bulk elements in cancer patients. Oncology 39:38-41
52. Vaidya SM, Kamalakar PL 1998 Copper and ceruloplasmin levels in serum of women with breast cancer. Indian J Med Sci 52:184-187
53. Yenisey C, Fadiloglu M, Onvural B 1996 Serum copper and ceruloplasmin concentrations in patients with primary breast cancer. Biochem Soc Trans 24:321S
54. Gupta SK, Shukla VK, Vaidya MP, Roy SK, Gupta S 1991 Serum trace elements and Cu/Zn ratio in breast cancer. J Surg Oncol 46:178-181
55. Garland M, Morris JS, Colditz GA, Stampfer MJ, Spate VL, Baskett CK, Rosner B, Speizer FE, Willett WC, Hunter DJ 1996 Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol 144:653-660
56. Garofalo JA, Ashikari H, Lesser ML, Menendez-Botet C, Cunningham-Rundles S, Schwartz MK, Good RA 1980 Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions. Cancer 46:2682-2685
57. Waalkes MP, Rehm S, Sass B, Konishi N, Ward JM 1991 Chronic carcinogenic and toxic effects of a single subcutaneous dose of cadmium in the male Fischer rat. Environ Res 55:40-50
58. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA 2006 Cadmium exposure and breast cancer risk. J Natl Cancer Inst 98:869-873
59. Adami HO, Lund E, Bergstrom R, Meirik O 1988 Cigarette smoking, alcohol consumption and risk of breast cancer in young women. Br J Cancer 58:832-837
60. Palmer JR, Rosenberg L, Clarke EA, Stolley PD, Warshauer ME, Zauber AG, Shapiro S 1991 Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol 134:1-13
61. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, Mak TW 1998 Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94:339-352
62. Stockwell HG, Lyman GH 1987 Cigarette smoking and the risk of female reproductive cancer. Am J Obstet Gynecol 157:35-40
63. Cui Y, Miller AB, Rohan TE 2006 Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat 100:293-299
64. Olson JE, Vachon CM, Vierkant RA, Sweeney C, Limburg PJ, Cerhan JR, Sellers TA 2005 Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer. Mayo Clin Proc 80:1423-1428
65. Li CI, Malone KE, Daling JR 2005 The relationship between various measures of cigarette smoking and risk of breast cancer among older women 65-79 years of age (United States). Cancer Causes Control 16:975-985
66. Band PR, Le ND, Fang R, Deschamps M 2002 Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 360:1044-1049
67. Al Delaimy WK, Cho E, Chen WY, Colditz G, Willet WC 2004 A prospective study of smoking and risk of breast cancer in young adult women. Cancer Epidemiol Biomarkers Prev 13:398-404
68. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A 2004 Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 96:29-37
69. Wells AJ 1991 Breast cancer, cigarette smoking, and passive smoking. Am J Epidemiol 133:208-210
70. Smith SJ, Deacon JM, Chilvers CE 1994 Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study Group. Br J Cancer 70:112-119
71. Sandler DP, Wilcox AJ, Everson RB 1985 Cumulative effects of lifetime passive smoking on cancer risk. Lancet 1:312-315
72. Morabia A, Bernstein MS, Bouchardy I, Kurtz J, Morris MA 2000 Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol 152:226-232
73. Clayton SJ, May FEB, Westley BR 1997 Insulin-like growth factors control the regulation of oestrogen and progesterone receptor expression by oestrogens. Mol Cell Endocrinol 128:57-68
74. Chang-Claude J, Kropp S, Jager B, Bartsch H, Risch A 2002 Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomarkers Prev 11:698-704
75. Russo IH, Medado J, Russo J 1989 Endocrine influences on mammary structure and development. In: Jones TC, Mohr U, Hunt RD, eds. Integument and mammary gland of laboratory animals. Berlin: Springer-Verlag; 252-266